EVE HEALTH GROUP LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.001 AUD | 0.00% |
|
0.00% | 0.00% |
| Feb. 28 | EVE Health Group Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
| 2023 | EVE Health Group Limited Reports Earnings Results for the Full Year Ended June 30, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
EVE Health Group Limited is an Australia-based vertically integrated producer of branded nutrition, health and wellness products. The Companyâs Meluka business provides branded wellness consumer products. Its Meluka business is focused on supporting sales of its digestive health products, in particular the P3 Gut Builder. It provides probiotic supplement powder system for improved digestive health. The functional gut nutrition solution is in the form of a three-step supplement powder system, each of which contain pre, pro and postbiotics as well as selected functional superfood ingredients in an easy to consume and versatile offering. The Company also offers honey and essential oil products. Its honey products include organic raw honey and raw honey probiotic concentrate. The Company has global reach and application to various markets across Australia and New Zealand, Asia Pacific and North America.
Sector
Other Specialty Retailers
Calendar
2024-08-27
- Q4 2024 Earnings Release (Projected)
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 3.44M | |
| +4.90% | 5.71B | |
| -11.81% | 4.42B | |
| +14.25% | 4.17B | |
| +4.23% | 1.85B | |
| -4.59% | 1.77B | |
| -13.78% | 1.26B | |
| -17.17% | 1.15B | |
| -42.26% | 736M | |
| -2.08% | 613M |
- Stock Market
- Equities
- EVE Stock
- News EVE Health Group Limited
- Eve Investments : Receives First Whole Foods Market Order; Shares Surge 17%
